-
2
-
-
77955558270
-
Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma
-
20670857 10.1016/j.jamcollsurg.2010.03.037
-
Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakashima A, Yuasa Y, Kondo N, Ohge H, Sueda T (2010) Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma. J Am Coll Surg 211:196-204
-
(2010)
J Am Coll Surg
, vol.211
, pp. 196-204
-
-
Murakami, Y.1
Uemura, K.2
Sudo, T.3
Hayashidani, Y.4
Hashimoto, Y.5
Nakashima, A.6
Yuasa, Y.7
Kondo, N.8
Ohge, H.9
Sueda, T.10
-
3
-
-
33751212765
-
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience
-
17114007 10.1016/j.gassur.2006.08.018
-
Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, Hodgin MB, Sauter PK, Hruban RH, Riall TS, Schulick RD, Choti MA, Lillemoe KD, Yeo CJ (2006) 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10:1199-1211
-
(2006)
J Gastrointest Surg
, vol.10
, pp. 1199-1211
-
-
Winter, J.M.1
Cameron, J.L.2
Campbell, K.A.3
Arnold, M.A.4
Chang, D.C.5
Coleman, J.6
Hodgin, M.B.7
Sauter, P.K.8
Hruban, R.H.9
Riall, T.S.10
Schulick, R.D.11
Choti, M.A.12
Lillemoe, K.D.13
Yeo, C.J.14
-
4
-
-
12144288807
-
Pancreatic cancer registry in Japan: 20 years of experience
-
15084961 10.1097/00006676-200404000-00002
-
Matsuno S, Egawa S, Fukuyama S, Motoi F, Sunamura M, Isaji S, Imaizumi T, Okada S, Kato H, Suda K, Nakao A, Hiraoka T, Hosotani R, Takeda K (2004) Pancreatic cancer registry in Japan: 20 years of experience. Pancreas 28:219-230
-
(2004)
Pancreas
, vol.28
, pp. 219-230
-
-
Matsuno, S.1
Egawa, S.2
Fukuyama, S.3
Motoi, F.4
Sunamura, M.5
Isaji, S.6
Imaizumi, T.7
Okada, S.8
Kato, H.9
Suda, K.10
Nakao, A.11
Hiraoka, T.12
Hosotani, R.13
Takeda, K.14
-
5
-
-
0034329115
-
Resected adenocarcinoma of the pancreas-616 patients: Results, outcomes, and prognostic indicators
-
11307091 10.1016/S1091-255X(00)80105-5 1:STN:280:DC%2BD3Mzlt1yqtA%3D%3D
-
Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, Sauter PK, Coleman J, Hruban RH, Lillemoe KD (2000) Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4:567-579
-
(2000)
J Gastrointest Surg
, vol.4
, pp. 567-579
-
-
Sohn, T.A.1
Yeo, C.J.2
Cameron, J.L.3
Koniaris, L.4
Kaushal, S.5
Abrams, R.A.6
Sauter, P.K.7
Coleman, J.8
Hruban, R.H.9
Lillemoe, K.D.10
-
6
-
-
77956416112
-
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine followed pancreatic cancer resection: A randomized controlled trial
-
European Study Group for Pancreatic Cancer 20823433 10.1001/jama.2010. 1275 1:CAS:528:DC%2BC3cXhtFequ7nE
-
Neoptolemos JP, Stocken DD, Bassi C, Ghaneh P, Cunningham D, Goldstein D, Padbury R, Moore MJ, Gallinger S, Mariette C, Wente MN, Izbicki JR, Friess H, Lerch MM, Dervenis C, Oláh A, Butturini G, Doi R, Lind PA, Smith D, Valle JW, Palmer DH, Buckels JA, Thompson J, McKay CJ, Rawcliffe CL, Büchler MW, European Study Group for Pancreatic Cancer (2010) Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine followed pancreatic cancer resection: a randomized controlled trial. JAMA 304:1073-1081
-
(2010)
JAMA
, vol.304
, pp. 1073-1081
-
-
Neoptolemos, J.P.1
Stocken, D.D.2
Bassi, C.3
Ghaneh, P.4
Cunningham, D.5
Goldstein, D.6
Padbury, R.7
Moore, M.J.8
Gallinger, S.9
Mariette, C.10
Wente, M.N.11
Izbicki, J.R.12
Friess, H.13
Lerch, M.M.14
Dervenis, C.15
Oláh, A.16
Butturini, G.17
Doi, R.18
Lind, P.A.19
Smith, D.20
Valle, J.W.21
Palmer, D.H.22
Buckels, J.A.23
Thompson, J.24
McKay, C.J.25
Rawcliffe, C.L.26
Büchler, M.W.27
more..
-
7
-
-
78049434513
-
Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: A randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study
-
20837948 10.1200/JCO.2010.30.3446
-
Van Laethem JL, Hammel P, Mornex F, Azria D, Van Tienhoven G, Vergauwe P, Peeters M, Polus M, Praet M, Mauer M, Collette L, Budach V, Lutz M, Van Cutsem E, Haustermans K (2010) Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study. J Clin Oncol 28:4450-4456
-
(2010)
J Clin Oncol
, vol.28
, pp. 4450-4456
-
-
Van Laethem, J.L.1
Hammel, P.2
Mornex, F.3
Azria, D.4
Van Tienhoven, G.5
Vergauwe, P.6
Peeters, M.7
Polus, M.8
Praet, M.9
Mauer, M.10
Collette, L.11
Budach, V.12
Lutz, M.13
Van Cutsem, E.14
Haustermans, K.15
-
8
-
-
40449113435
-
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial
-
18319412 10.1001/jama.299.9.1019 1:CAS:528:DC%2BD1cXjtVSltL0%3D
-
Regine WF, Winter KA, Abrams RA, Safran H, Hoffman JP, Konski A, Benson AB, Macdonald JS, Kudrimoti MR, Fromm ML, Haddock MG, Schaefer P, Willett CG, Rich TA (2008) Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA 299:1019-1026
-
(2008)
JAMA
, vol.299
, pp. 1019-1026
-
-
Regine, W.F.1
Winter, K.A.2
Abrams, R.A.3
Safran, H.4
Hoffman, J.P.5
Konski, A.6
Benson, A.B.7
MacDonald, J.S.8
Kudrimoti, M.R.9
Fromm, M.L.10
Haddock, M.G.11
Schaefer, P.12
Willett, C.G.13
Rich, T.A.14
-
9
-
-
70249099504
-
A randomized phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for pancreatic cancer
-
19690548 10.1038/sj.bjc.6605256 1:CAS:528:DC%2BD1MXhtV2qsrjN
-
Ueno H, Kosuge T, Matsuyama Y, Yamamoto J, Nakao A, Egawa S, Doi R, Monden M, Hatori T, Tanaka M, Shimada M, Kanemitsu K (2009) A randomized phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for pancreatic cancer. Br J Cancer 101:908-915
-
(2009)
Br J Cancer
, vol.101
, pp. 908-915
-
-
Ueno, H.1
Kosuge, T.2
Matsuyama, Y.3
Yamamoto, J.4
Nakao, A.5
Egawa, S.6
Doi, R.7
Monden, M.8
Hatori, T.9
Tanaka, M.10
Shimada, M.11
Kanemitsu, K.12
-
10
-
-
33846405332
-
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial
-
17227978 10.1001/jama.297.3.267 1:CAS:528:DC%2BD2sXotVCmug%3D%3D
-
Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C, Gutberlet K, Kettner E, Schmalenberg H, Weigang-Koehler K, Bechstein WO, Niedergethmann M, Schmidt-Wolf I, Roll L, Doerken B, Riess H (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267-277
-
(2007)
JAMA
, vol.297
, pp. 267-277
-
-
Oettle, H.1
Post, S.2
Neuhaus, P.3
Gellert, K.4
Langrehr, J.5
Ridwelski, K.6
Schramm, H.7
Fahlke, J.8
Zuelke, C.9
Burkart, C.10
Gutberlet, K.11
Kettner, E.12
Schmalenberg, H.13
Weigang-Koehler, K.14
Bechstein, W.O.15
Niedergethmann, M.16
Schmidt-Wolf, I.17
Roll, L.18
Doerken, B.19
Riess, H.20
more..
-
11
-
-
12144287320
-
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer
-
European Study Group for Pancreatic Cancer 15028824 10.1056/NEJMoa032295 1:CAS:528:DC%2BD2cXit12rtr8%3D
-
Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, Falconi M, Pederzoli P, Pap A, Spooner D, Kerr DJ, Büchler MW, European Study Group for Pancreatic Cancer (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200-1210
-
(2004)
N Engl J Med
, vol.350
, pp. 1200-1210
-
-
Neoptolemos, J.P.1
Stocken, D.D.2
Friess, H.3
Bassi, C.4
Dunn, J.A.5
Hickey, H.6
Beger, H.7
Fernandez-Cruz, L.8
Dervenis, C.9
Lacaine, F.10
Falconi, M.11
Pederzoli, P.12
Pap, A.13
Spooner, D.14
Kerr, D.J.15
Büchler, M.W.16
-
12
-
-
0037108106
-
Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma
-
Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract 12365016 10.1002/cncr.10831
-
Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T, Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract (2002) Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95:1685-1695
-
(2002)
Cancer
, vol.95
, pp. 1685-1695
-
-
Takada, T.1
Amano, H.2
Yasuda, H.3
Nimura, Y.4
Matsushiro, T.5
Kato, H.6
Nagakawa, T.7
Nakayama, T.8
-
13
-
-
0033497862
-
Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group
-
10615932 10.1097/00000658-199912000-00006 1:STN:280: DC%2BD3c%2FotFKkug%3D%3D
-
Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH, Arnaud JP, Gonzalez DG, de Wit LT, Hennipman A, Wils J (1999) Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230:776-784
-
(1999)
Ann Surg
, vol.230
, pp. 776-784
-
-
Klinkenbijl, J.H.1
Jeekel, J.2
Sahmoud, T.3
Van Pel, R.4
Couvreur, M.L.5
Veenhof, C.H.6
Arnaud, J.P.7
Gonzalez, D.G.8
De Wit, L.T.9
Hennipman, A.10
Wils, J.11
-
14
-
-
0027461223
-
Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater-results of a controlled, prospective, randomised multicentre study
-
8471327 10.1016/S0959-8049(05)80349-1 1:STN:280:DyaK3s3ivFWhtQ%3D%3D
-
Bakkevold KE, Arnesjo B, Dahl O, Kambestad B (1993) Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater-results of a controlled, prospective, randomised multicentre study. Eur J Cancer 29A:698-703
-
(1993)
Eur J Cancer
, vol.29
, pp. 698-703
-
-
Bakkevold, K.E.1
Arnesjo, B.2
Dahl, O.3
Kambestad, B.4
-
15
-
-
0023262033
-
Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer
-
Gastrointestinal Tumour Study Group 10.1002/1097-0142(19870615)59: 12<2006: AID-CNCR2820591206>3.0.CO;2-B
-
Gastrointestinal Tumour Study Group (1987) Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59:2006-2010
-
(1987)
Cancer
, vol.59
, pp. 2006-2010
-
-
-
16
-
-
79958024180
-
Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada
-
21319156 10.1002/cncr.25954
-
Lima IS, Yasui Y, Scarfe A, Winget M (2011) Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada. Cancer 117:3833-3840
-
(2011)
Cancer
, vol.117
, pp. 3833-3840
-
-
Lima, I.S.1
Yasui, Y.2
Scarfe, A.3
Winget, M.4
-
17
-
-
79958035214
-
Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: A systematic review and meta-analysis
-
21642686 10.1001/jama.2011.749 1:CAS:528:DC%2BC3MXntlOnsLw%3D
-
Biagi JJ, Raphael MJ, Mackillop WJ, Kong W, King WD, Booth CM (2011) Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA 305:2335-2342
-
(2011)
JAMA
, vol.305
, pp. 2335-2342
-
-
Biagi, J.J.1
Raphael, M.J.2
MacKillop, W.J.3
Kong, W.4
King, W.D.5
Booth, C.M.6
-
18
-
-
77949488886
-
Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis
-
20138505 10.1016/j.ejca.2010.01.020
-
Des Guetz G, Nicolas P, Perret GY, Morere JF, Uzzan B (2010) Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis. Eur J Cancer 46:1049-1055
-
(2010)
Eur J Cancer
, vol.46
, pp. 1049-1055
-
-
Des Guetz, G.1
Nicolas, P.2
Perret, G.Y.3
Morere, J.F.4
Uzzan, B.5
-
19
-
-
68049125885
-
Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer
-
19581846 10.1007/DCR.0b013e3181a51173 (discussion 1064)
-
Cheung WY, Neville BA, Earle CC (2009) Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer. Dis Colon Rectum 52:1054-1063 (discussion 1064)
-
(2009)
Dis Colon Rectum
, vol.52
, pp. 1054-1063
-
-
Cheung, W.Y.1
Neville, B.A.2
Earle, C.C.3
-
20
-
-
33751581368
-
Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer
-
17078055 10.1002/cncr.22316
-
Hershman D, Hall MJ, Wang X, Jacobson JS, McBride R, Grann VR, Neugut AI (2006) Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer 107:2581-2588
-
(2006)
Cancer
, vol.107
, pp. 2581-2588
-
-
Hershman, D.1
Hall, M.J.2
Wang, X.3
Jacobson, J.S.4
McBride, R.5
Grann, V.R.6
Neugut, A.I.7
-
21
-
-
84655176817
-
Optimal timing of adjuvant treatment in patients with early breast cancer
-
20473647 10.1007/s12032-010-9566-4 1:CAS:528:DC%2BC3MXhsFWjtr7P
-
Alkis N, Durnali AG, Arslan UY, Kocer M, Onder FO, Tokluoglu S, Celenkoglu G, Muallaoglu S, Utkan G, Ulas A, Altundag K (2011) Optimal timing of adjuvant treatment in patients with early breast cancer. Med Oncol 28:1255-1259
-
(2011)
Med Oncol
, vol.28
, pp. 1255-1259
-
-
Alkis, N.1
Durnali, A.G.2
Arslan, U.Y.3
Kocer, M.4
Onder, F.O.5
Tokluoglu, S.6
Celenkoglu, G.7
Muallaoglu, S.8
Utkan, G.9
Ulas, A.10
Altundag, K.11
-
22
-
-
33750632779
-
Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer
-
17015884 10.1200/JCO.2005.01.6089
-
Lohrisch C, Paltiel C, Gelmon K, Speers C, Taylor S, Barnett J, Olivotto IA (2006) Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol 24:4888-4894
-
(2006)
J Clin Oncol
, vol.24
, pp. 4888-4894
-
-
Lohrisch, C.1
Paltiel, C.2
Gelmon, K.3
Speers, C.4
Taylor, S.5
Barnett, J.6
Olivotto, I.A.7
-
23
-
-
0033966381
-
Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group
-
10653873 1:CAS:528:DC%2BD3cXht1Kmtb8%3D
-
Colleoni M, Bonetti M, Coates AS, Castiglione-Gertsch M, Gelber RD, Price K, Rudenstam CM, Lindtner J, Collins J, Thürlimann B, Holmberg S, Veronesi A, Marini G, Goldhirsch A (2000) Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group. J Clin Oncol 18:584-590
-
(2000)
J Clin Oncol
, vol.18
, pp. 584-590
-
-
Colleoni, M.1
Bonetti, M.2
Coates, A.S.3
Castiglione-Gertsch, M.4
Gelber, R.D.5
Price, K.6
Rudenstam, C.M.7
Lindtner, J.8
Collins, J.9
Thürlimann, B.10
Holmberg, S.11
Veronesi, A.12
Marini, G.13
Goldhirsch, A.14
-
24
-
-
44349154677
-
Adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma
-
18367131 10.1016/j.amjsurg.2007.04.018 1:CAS:528:DC%2BD1cXmsFKqtrg%3D
-
Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakagawa N, Ohge H, Sueda T (2008) Adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma. Am J Surg 195:757-762
-
(2008)
Am J Surg
, vol.195
, pp. 757-762
-
-
Murakami, Y.1
Uemura, K.2
Sudo, T.3
Hayashidani, Y.4
Hashimoto, Y.5
Nakagawa, N.6
Ohge, H.7
Sueda, T.8
-
25
-
-
57849164479
-
Impact of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for adenocarcinoma of the body or tail of the pancreas
-
18704593 10.1007/s11605-008-0650-4
-
Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Ohge H, Sueda T (2009) Impact of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for adenocarcinoma of the body or tail of the pancreas. J Gastrointest Surg 13:85-92
-
(2009)
J Gastrointest Surg
, vol.13
, pp. 85-92
-
-
Murakami, Y.1
Uemura, K.2
Sudo, T.3
Hayashidani, Y.4
Hashimoto, Y.5
Ohge, H.6
Sueda, T.7
-
26
-
-
84863726640
-
Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma
-
22331838 10.1002/jso.23068 1:CAS:528:DC%2BC38XpvVehsrg%3D
-
Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Kondo N, Nakagawa N, Sueda T (2012) Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma. J Surg Oncol 106:174-180
-
(2012)
J Surg Oncol
, vol.106
, pp. 174-180
-
-
Murakami, Y.1
Uemura, K.2
Sudo, T.3
Hashimoto, Y.4
Nakashima, A.5
Kondo, N.6
Nakagawa, N.7
Sueda, T.8
-
27
-
-
33847175519
-
Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma
-
17278119 10.1002/jso.20668
-
Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, Sueda T (2007) Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma. J Surg Oncol 95:207-212
-
(2007)
J Surg Oncol
, vol.95
, pp. 207-212
-
-
Murakami, Y.1
Uemura, K.2
Hayashidani, Y.3
Sudo, T.4
Hashimoto, Y.5
Ohge, H.6
Sueda, T.7
-
28
-
-
46449126875
-
Prognostic impact of perineural invasion following pancreatoduodenectomy with lymphadenectomy for ampullary carcinoma
-
18095164 10.1007/s10620-007-0117-6
-
Sudo T, Murakami Y, Uemura K, Hayashidani Y, Hashimoto Y, Ohge H, Shimamoto F, Sueda T (2008) Prognostic impact of perineural invasion following pancreatoduodenectomy with lymphadenectomy for ampullary carcinoma. Dig Dis Sci 53:2281-2286
-
(2008)
Dig Dis Sci
, vol.53
, pp. 2281-2286
-
-
Sudo, T.1
Murakami, Y.2
Uemura, K.3
Hayashidani, Y.4
Hashimoto, Y.5
Ohge, H.6
Shimamoto, F.7
Sueda, T.8
-
29
-
-
33747359052
-
Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma
-
10.1016/j.surg.2006.03.017
-
Murakami Y, Uemura K, Ohge H, Hayashidani Y, Sudo T, Sueda T (2006) Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma. Surgery 140:443-453
-
(2006)
Surgery
, vol.140
, pp. 443-453
-
-
Murakami, Y.1
Uemura, K.2
Ohge, H.3
Hayashidani, Y.4
Sudo, T.5
Sueda, T.6
-
30
-
-
77955471956
-
Prognostic impact of para-aortic lymph node metastasis in pancreatic carcinoma
-
20376442 10.1007/s00268-010-0577-2
-
Murakami Y, Uemura K, Sudo T, Hashimoto Y, Yuasa Y, Sueda T (2010) Prognostic impact of para-aortic lymph node metastasis in pancreatic carcinoma. World J Surg 34:1900-1907
-
(2010)
World J Surg
, vol.34
, pp. 1900-1907
-
-
Murakami, Y.1
Uemura, K.2
Sudo, T.3
Hashimoto, Y.4
Yuasa, Y.5
Sueda, T.6
-
32
-
-
77956340670
-
Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer
-
20336387 10.1245/s10434-010-1033-0
-
Kondo N, Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Nakashima A, Sakabe R, Shigemoto N, Kato Y, Ohge H, Sueda T (2010) Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer. Ann Surg Oncol 17:2321-2329
-
(2010)
Ann Surg Oncol
, vol.17
, pp. 2321-2329
-
-
Kondo, N.1
Murakami, Y.2
Uemura, K.3
Hayashidani, Y.4
Sudo, T.5
Hashimoto, Y.6
Nakashima, A.7
Sakabe, R.8
Shigemoto, N.9
Kato, Y.10
Ohge, H.11
Sueda, T.12
-
33
-
-
0025141337
-
What is the evidence that tumors are angiogenesis dependent?
-
1688381 10.1093/jnci/82.1.4 1:STN:280:DyaK3c%2FnvF2qug%3D%3D
-
Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-6
-
(1990)
J Natl Cancer Inst
, vol.82
, pp. 4-6
-
-
Folkman, J.1
-
34
-
-
0023219775
-
Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cells
-
3495896 1:STN:280:DyaL2s3jsV2jtA%3D%3D
-
Eggermont AM, Steller EP, Sugarbaker PH (1987) Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cells. Surgery 102:71-78
-
(1987)
Surgery
, vol.102
, pp. 71-78
-
-
Eggermont, A.M.1
Steller, E.P.2
Sugarbaker, P.H.3
-
35
-
-
39749188328
-
No mortality after 150 consecutive pancreatoduodenctomies with duct-to-mucosa pancreaticogastrostomy
-
18050288 10.1002/jso.20903
-
Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Nakagawa N, Ohge H, Sueda T (2008) No mortality after 150 consecutive pancreatoduodenctomies with duct-to-mucosa pancreaticogastrostomy. J Surg Oncol 97:205-209
-
(2008)
J Surg Oncol
, vol.97
, pp. 205-209
-
-
Murakami, Y.1
Uemura, K.2
Hayashidani, Y.3
Sudo, T.4
Hashimoto, Y.5
Nakagawa, N.6
Ohge, H.7
Sueda, T.8
-
36
-
-
0029835349
-
Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumour selective cytotoxicity of 5-fluorouracil by two biochemical modulators
-
8862723 10.1097/00001813-199607000-00010 1:CAS:528:DyaK28Xltleru78%3D
-
Shirasaka T, Shimamoto Y, Ohshimo H, Yamaguchi M, Kato T, Yonekura K, Fukushima M (1996) Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumour selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs 7:548-557
-
(1996)
Anticancer Drugs
, vol.7
, pp. 548-557
-
-
Shirasaka, T.1
Shimamoto, Y.2
Ohshimo, H.3
Yamaguchi, M.4
Kato, T.5
Yonekura, K.6
Fukushima, M.7
-
37
-
-
79960209335
-
Randomized phase III study of gemcitabine plus S-1 (GS) versus S-1 versus gemcitabine (GEM) in unresectable advanced pancreatic cancer (PC) in Japan and Taiwan: GEST study
-
abstr 4007
-
Ioka T, Ikeda S, Ohkawa H, Yanagimoto H, Fukutomi A, Sugimori K, Baba H, Yamao K, Shimamura T, Chen JS, Mizumoto K, Furuse J, Funakoshi A, Hatori T, Yamaguchi T, Egawa S, Sato A, Ohashi Y, Cheng AL, Okusaka T (2011) Randomized phase III study of gemcitabine plus S-1 (GS) versus S-1 versus gemcitabine (GEM) in unresectable advanced pancreatic cancer (PC) in Japan and Taiwan: GEST study. J Clin Oncol 29 (suppl; abstr 4007)
-
(2011)
J Clin Oncol
, vol.29
, Issue.SUPPL.
-
-
Ioka, T.1
Ikeda, S.2
Ohkawa, H.3
Yanagimoto, H.4
Fukutomi, A.5
Sugimori, K.6
Baba, H.7
Yamao, K.8
Shimamura, T.9
Chen, J.S.10
Mizumoto, K.11
Furuse, J.12
Funakoshi, A.13
Hatori, T.14
Yamaguchi, T.15
Egawa, S.16
Sato, A.17
Ohashi, Y.18
Cheng, A.L.19
Okusaka, T.20
more..
|